These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7216613)

  • 1. Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonists.
    Hruby VJ; Mosberg HI; Hadley ME; Chan WY; Powell AM
    Int J Pept Protein Res; 1980 Nov; 16(5):372-81. PubMed ID: 7216613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological, conformational and dynamic properties of cycloleucine-2 analogues of oxytocin and [1-penicillamine]oxytocin.
    Hruby VJ; Rockway TW; Viswanatha V; Chan WY
    Int J Pept Protein Res; 1983 Jan; 21(1):24-34. PubMed ID: 6826279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational comparisons of oxytocin agonists, partial agonists, and antagonists using laser Raman and circular dichroism spectroscopy. Examination of 1-penicillamine and diastereoisomeric analogues.
    Hruby VJ; Mosberg HI; Fox JW; Tu AT
    J Biol Chem; 1982 May; 257(9):4916-24. PubMed ID: 7068672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism.
    Meraldi JP; Hruby VJ; Brewster AI
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1373-7. PubMed ID: 266179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution.
    Mosberg HI; Hruby VJ; Meraldi JP
    Biochemistry; 1981 May; 20(10):2822-8. PubMed ID: 7248250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and bioassay.
    Fric I; Hlavacek J; Rockway TW; Chan WY; Hruby VJ
    J Protein Chem; 1990 Feb; 9(1):9-15. PubMed ID: 2340080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs.
    Bélec L; Maletinska L; Slaninová J; Lubell WD
    J Pept Res; 2001 Sep; 58(3):263-73. PubMed ID: 11576333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of effective in vivo antagonists of rat uterus and milk ejection responses to oxytocin.
    Sawyer WH; Haldar J; Gazis D; Seto J; Bankowski K; Lowbridge J; Turan A; Manning M
    Endocrinology; 1980 Jan; 106(1):81-91. PubMed ID: 7349976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
    Rekowski P; Melin P; Lammek B
    Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity.
    Lowbridge J; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1977 Jan; 20(1):120-3. PubMed ID: 833810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxytocic and antiprostaglandin-releasing effects of oxytocin antagonists in pregnant rats and pregnant human myometrial strips.
    Chan WY; Powell AM; Hruby VJ
    Endocrinology; 1982 Jul; 111(1):48-54. PubMed ID: 6953012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.